Philips stock heads into next quarter after Q3 margin expansion

Royal Philips reported stronger third-quarter orders and wider margins on November 3, while the company maintained its full-year outlook. The Philips third-quarter results showed comparable order intake up 8 percent and group sales of 4.4 billion euros, with comparable sales growth of 3 percent.

Adjusted EBITA margin expanded by 70 basis points to 13.0 percent. Philips attributed the improvement to higher sales, stronger gross margin and productivity measures, while cost inflation partly offset the gains.

Outlook stays intact after strong quarter

Management reiterated its 2026 targets for comparable sales growth of 3 percent to 4.5 percent, an adjusted EBITA margin of 13.5 percent to 14.0 percent and free cash flow of 1.5 billion euros to 1.7 billion euros. The margin outlook includes an expected benefit from a United States tariff refund.

Legal exposure remains part of the operating context. The outlook assumes payment of the United States Department of Justice settlement in the first quarter of 2027 and excludes other ongoing Philips Respironics-related proceedings.

New imaging system expands portfolio

On November 2, Philips announced United States commercial availability of the HyperVue Integrated System. The Philips announcement describes a single-room configuration combining coronary imaging and physiology assessment for use in the cathlab.

The real-time quote of Philips stock showed a Lang & Schwarz price of 27.29 euros at 12:14 CET on Saturday, November 7.

The Euro Stoxx 50 provides the broader European equity-market context.

More news and analyses on Philips stock.